--- title: "Pre-market hot trades in US stocks: BVC pre-market down 8.27%; A SPAC III Acquisition pre-market up 7.67%" type: "News" locale: "en" url: "https://longbridge.com/en/news/271636137.md" description: "BVC pre-market down 8.27%; A SPAC III Acquisition pre-market up 7.67%; VS MEDIA pre-market up 55.11%; Cyclerion Therapeutics pre-market up 43.48%; Brand Engagement Network pre-market up 28.18%" datetime: "2026-01-06T10:17:19.000Z" locales: - [zh-CN](https://longbridge.com/zh-CN/news/271636137.md) - [en](https://longbridge.com/en/news/271636137.md) - [zh-HK](https://longbridge.com/zh-HK/news/271636137.md) --- # Pre-market hot trades in US stocks: BVC pre-market down 8.27%; A SPAC III Acquisition pre-market up 7.67% **Popular Pre-Market Trades in US Stocks** BVC is down 8.27% in pre-market trading. Based on recent news, 1. On January 3rd, BitVentures Limited announced its official entry into the cryptocurrency mining sector. The company purchased multiple batches of Antminer mining machines to mine Bitcoin, Litecoin, and Dogecoin at data centers in the United States, with a supporting power scale of approximately 0.5 megawatts. This move is seen by the market as an important bet for its business revival, but due to the company's long-term poor performance, with a cumulative stock price return of about -89%, this transformation failed to immediately boost market confidence, leading to a decline in stock price. 2. On January 3rd, less than two weeks after BitVentures Limited completed its name change on NASDAQ, it launched its first digital asset business. The company stated that the mining business will be the foundation of its digital asset strategy, with plans to expand into staking and node operations in the future. However, the market remains skeptical about its ability to successfully transform, further exacerbating the decline in stock price. 3. On January 3rd, BitVentures Limited recorded zero revenue in the first half of fiscal year 2025, a significant drop from $17.4 million in the same period last year. The company previously operated under the name Santech Holdings, and its long-term poor performance has heightened market concerns about its financial situation, putting pressure on its stock price. The cryptocurrency market is highly volatile, and investors should exercise caution. A SPAC III Acquisition is up 7.67% in pre-market trading, with no significant news recently. The trading is active, and the capital flow is evident. Considering the sector and industry trends, this stock shows significant volatility, and the specific reasons need further observation. **Top Gainers in Pre-Market Trading in US Stocks** VS MEDIA is up 55.11% in pre-market trading. Based on recent key news: 1. On January 5th, VS Media announced that the effective date for its reverse stock split of Class A common stock has been postponed to January 12th. Due to unexpected delays in regulatory approval, the stock price surged significantly by 55.11% in pre-market trading. Source: GlobeNewswire 2. On January 5th, VS Media announced in Hong Kong that the effective date for its reverse stock split has been adjusted to January 12th. This move was due to challenges in obtaining the necessary regulatory approvals, positively impacting the stock price. Source: GlobeNewswire 3. On January 2nd, VS Media announced a 1-for-20 stock consolidation, leading to stock price fluctuations. Source: GlobeNewswire The digital creator industry is facing regulatory challenges. Cyclerion Therapeutics is up 43.48% in pre-market trading. Based on recent news, 1. On January 5th, Cyclerion Therapeutics announced a strategic agreement with MedSteer and is advancing the Phase II proof-of-concept study for CYC-126 in treating refractory depression. Following this announcement, the market expressed optimism about the company's prospects, driving a significant increase in stock price On January 5th, the company announced plans to complete equipment integration and finalize its drug delivery system in the second half of this year, in order to initiate the Phase II proof-of-concept study for CYC-126. This progress further boosted investor confidence, driving up the stock price. The biopharmaceutical industry has performed strongly recently, with investors focusing on the progress of new drug development. Brand Engagement Network rose 28.18% in pre-market trading, with no significant news recently. Trading is active, and there is a clear flow of funds. Considering the sector and industry trends, the stock shows significant volatility, and the specific reasons need further observation ### Related Stocks - [BVC.US](https://longbridge.com/en/quote/BVC.US.md) - [ASPC.US](https://longbridge.com/en/quote/ASPC.US.md) - [VSME.US](https://longbridge.com/en/quote/VSME.US.md) - [CYCN.US](https://longbridge.com/en/quote/CYCN.US.md) ## Related News & Research - [SPAC Ocean Capital Acquisition prices $100 million IPO, targeting established businesses](https://longbridge.com/en/news/289188340.md) - [SPAC Terminates ReserveOne Deal, Plans Velos Rebranding](https://longbridge.com/en/news/289645018.md) - [Snow Rothschild Acquisition Completes $226 Million SPAC IPO, Signs Underwriting, Warrant, Trust Pacts](https://longbridge.com/en/news/289639796.md) - [SPAC Southern Cross Acquisition I files for a $100 million IPO](https://longbridge.com/en/news/289608159.md) - [With Growing Hype Ahead of the SpaceX IPO, the IPFX SPAC Merger With Quantum Space Looks Interesting](https://longbridge.com/en/news/289603405.md)